Ad is loading...
BMRA
Price
$0.35
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
65 days until earnings call
NVCR
Price
$16.11
Change
-$0.46 (-2.78%)
Updated
Nov 15 closing price
95 days until earnings call
Ad is loading...

BMRA vs NVCR

Header iconBMRA vs NVCR Comparison
Open Charts BMRA vs NVCRBanner chart's image
Biomerica
Price$0.35
Change-$0.00 (-0.00%)
Volume$48.25K
CapitalizationN/A
NovoCure
Price$16.11
Change-$0.46 (-2.78%)
Volume$733.69K
CapitalizationN/A
BMRA vs NVCR Comparison Chart
Loading...
BMRA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BMRA vs. NVCR commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRA is a Sell and NVCR is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BMRA: $0.35 vs. NVCR: $16.11)
Brand notoriety: BMRA and NVCR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BMRA: 26% vs. NVCR: 72%
Market capitalization -- BMRA: $14M vs. NVCR: $1.66B
BMRA [@Medical Specialties] is valued at $14M. NVCR’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRA’s FA Score shows that 1 FA rating(s) are green whileNVCR’s FA Score has 1 green FA rating(s).

  • BMRA’s FA Score: 1 green, 4 red.
  • NVCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both BMRA and NVCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRA’s TA Score shows that 4 TA indicator(s) are bullish while NVCR’s TA Score has 2 bullish TA indicator(s).

  • BMRA’s TA Score: 4 bullish, 4 bearish.
  • NVCR’s TA Score: 2 bullish, 9 bearish.
According to our system of comparison, BMRA is a better buy in the short-term than NVCR.

Price Growth

BMRA (@Medical Specialties) experienced а -10.49% price change this week, while NVCR (@Medical Specialties) price change was -7.63% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

BMRA is expected to report earnings on Jan 21, 2025.

NVCR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCR($1.66B) has a higher market cap than BMRA($14M). NVCR YTD gains are higher at: 7.904 vs. BMRA (-72.072). BMRA has higher annual earnings (EBITDA): -5.97M vs. NVCR (-177.45M). NVCR has more cash in the bank: 911M vs. BMRA (7.13M). BMRA has less debt than NVCR: BMRA (937K) vs NVCR (596M). NVCR has higher revenues than BMRA: NVCR (509M) vs BMRA (5.5M).
BMRANVCRBMRA / NVCR
Capitalization14M1.66B1%
EBITDA-5.97M-177.45M3%
Gain YTD-72.0727.904-912%
P/E RatioN/AN/A-
Revenue5.5M509M1%
Total Cash7.13M911M1%
Total Debt937K596M0%
FUNDAMENTALS RATINGS
BMRA vs NVCR: Fundamental Ratings
BMRA
NVCR
OUTLOOK RATING
1..100
9718
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
6461
P/E GROWTH RATING
1..100
10011
SEASONALITY SCORE
1..100
1250

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRA's Valuation (32) in the Medical Specialties industry is significantly better than the same rating for NVCR (100). This means that BMRA’s stock grew significantly faster than NVCR’s over the last 12 months.

BMRA's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVCR (100). This means that BMRA’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's SMR Rating (95) in the Medical Specialties industry is in the same range as BMRA (97). This means that NVCR’s stock grew similarly to BMRA’s over the last 12 months.

NVCR's Price Growth Rating (61) in the Medical Specialties industry is in the same range as BMRA (64). This means that NVCR’s stock grew similarly to BMRA’s over the last 12 months.

NVCR's P/E Growth Rating (11) in the Medical Specialties industry is significantly better than the same rating for BMRA (100). This means that NVCR’s stock grew significantly faster than BMRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRANVCR
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 12 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 5 days ago
88%
View a ticker or compare two or three
Ad is loading...
BMRA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRIDX12.55-0.06
-0.48%
Harbor Diversified Intl All Cp Admin
PRDMX49.87-0.52
-1.03%
T. Rowe Price Diversified Mid Cap Gr
RCMPX16.34-0.19
-1.15%
Lazard International Quality Gr R6
JMGRX153.01-1.90
-1.23%
Janus Henderson Enterprise I
LYFCX12.76-0.29
-2.22%
AlphaCentric Life Sciences & Hlthcare C

BMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRA has been loosely correlated with ZIMV. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRA jumps, then ZIMV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRA
1D Price
Change %
BMRA100%
-0.82%
ZIMV - BMRA
39%
Loosely correlated
-2.83%
NVCR - BMRA
28%
Poorly correlated
-2.78%
ZJYL - BMRA
25%
Poorly correlated
-2.92%
CTKB - BMRA
25%
Poorly correlated
-7.32%
SINT - BMRA
24%
Poorly correlated
-6.85%
More

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with MASS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
-2.78%
MASS - NVCR
45%
Loosely correlated
+0.42%
VCYT - NVCR
44%
Loosely correlated
-2.97%
GH - NVCR
44%
Loosely correlated
-3.64%
KIDS - NVCR
43%
Loosely correlated
+1.06%
TWST - NVCR
43%
Loosely correlated
-5.31%
More